Skip to content

The effect of spinae plane block and retrolaminar block on pain control

Comparison of the effect of spinae plane block and retrolaminar block,under ultrasound guidance, on pain after laparoscopic upper abdominal surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120814010599N28
Enrollment
70
Registered
2021-04-04
Start date
2021-04-22
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Pain, not elsewhere classified

Interventions

Intervention 1: Intervention group:In the group that intends to perform the Spinae plain ? erector block, the patients are placed in the lateral position after monitoring, and on the surgical side aft

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients' consent to enter the study Patients with ASA <1 & 2 Patients aged 20-60 years Patients undergoing upper abdominal laparoscopic surgery

Exclusion criteria

Exclusion criteria: Emergency patients History of ropiavacaine allergy Patients who have received analgesia in a recent day Patients with a Body Mass Index>35 Patients with or underlying liver and kidney disease and coagulopathy Patients addicted to opioids

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: After the end of surgery and 20 minutes, 2 hours, 4 hours, 6 hours, 12 hours and 24 hours after surgery. Method of measurement: Using Numeric Rating Scale (NRS).

Secondary

MeasureTime frame
Patient satisfaction. Timepoint: After the end of surgery and twenty minutes, 2 hours, 4 hours, 6 hours, 12 hours and 24 hours after surgery. Method of measurement: poor:0,moderate:1,good:2,very good:3,excellent:4.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPoupak Rahimzadeh

Iran University of Medical Sciences

p-rahimzadeh@tums.ac.ir+98 21 6650 9059

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026